Critical Diagnostics

2018	01/03/18	Cardiac Biomarker Company Critical Diagnostics Completes $8.5 Million Financing And Announces Two Promotions
2016	03/15/16	Critical Diagnostics Inks Exclusive Worldwide License Agreement For New Heart Failure Biomarker sNEP
	01/08/16	Critical Diagnostics Announces Key Promotions
2015	07/24/15	Multiple Studies Show Superiority of Critical Diagnostics’ ST2 Over BNP, NT-proBNP and Other Heart Failure Biomarkers
	06/02/15	New Generation of Drugs Hold Great Promise in Saving and Improving the Lives of Millions of Heart Failure Patients
	03/24/15	Critical Diagnostics’ Presage® ST2 Assay Cardiac Biomarker Test Receives China Food and Drug Administration Clearance
	03/17/15	Heart Failure Study Performed by Cleveland Clinic Shows Serial Testing with Cardiac Biomarker ST2 Predicts Outcomes of Hospitalized Patients
	03/17/15	Opinions of 18 World-Renowned Experts Contained in Consensus Paper on Role of Cardiac Biomarker ST2 in Heart Failure Care
	03/10/15	Critical Diagnostics Launches Rapid Test for Managing Heart Failure Patients
	03/06/15	New White Paper Reveals Cardiovascular Pandemic Affecting Tens of Millions of People Worldwide
	01/12/15	Critical Diagnostics Begins 2015 With Landmark Reimbursement and CPT Coding Decisions For Its Heart Failure Biomarker, ST2